The 20 Best Dysarthria Doctors Near Me in Ann Arbor, MI

Stephen Goutman, MD, MS is an Associate Professor in the Department of Neurology and Director of the Amyotrophic Lateral Sclerosis Clinic and ALS Center of Excellence at Michigan Medicine. After obtaining a degree in neuroscience at the Johns Hopkins University (Baltimore, MD), Dr. Goutman completed his medical degree at the University of Chicago Pritzker School of Medicine (Chicago, IL) and his neurology residency and neuromuscular fellowship at Cleveland Clinic (Cleveland, OH). He received a Master’s in Clinical Research Design and Statistical Analysis at the University of Michigan (Ann Arbor, MI).Dr. Goutman evaluates and treats patients with neuromuscular diseases and is interested in diseases such as myasthenia gravis and muscle diseases. His area of expertise is amyotrophic lateral sclerosis (ALS)/Lou Gehrig’s Disease where his focus is delivering comprehensive and compassionate care. He is Director of the ALS Clinic, an ALS Association Certified Center of Excellence (http://www.umich-als.org/), where he leads a team of providers that care for persons with ALS and their families. Dr. Goutman is inspired by his patients and thus aims to provide the highest level of care.Dr. Goutman’s research is focused on identifying causes of and treatments for ALS. He leads research efforts that received funding by the National Institutes of Health and the Centers for Disease Control aimed at identifying environmental risk factors and causes of ALS (https://umhealthresearch.org/#studies/HUM00028826) and showed, in an article that received widespread attention, a connection between ALS and organochlorine pesticides (https://jamanetwork.com/journals/jamaneurology/fullarticle/2519875). Dr. Goutman also helps direct the University of Michigan ALS Biorepository which provides essential resources to ALS researchers within and external to the University of Michigan enabling studies into areas of ALS genetics, epigenetics, and immunology.Dr. Goutman is a site principal investigator of several multisite clinical trials focused on identifying new ALS treatments and causes and is an active participant with the Northeast ALS Consortium (NEALS) to improve care for ALS. He received a 2016 Young Investigator Award by the World Federation of Neurology Research Group on Motor Neuron Diseases. Dr. Goutman is rated as a Distinguished provider by MediFind in the treatment of Dysarthria. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), and Spinal and Bulbar Muscular Atrophy. Dr. Goutman is board certified in Neurology, Neuromuscular Medicine, and Electrodiagnostic Medicine.

Punithavathy Vijayakumar is a Neurologist and a Sleep Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Vijayakumar is rated as an Advanced provider by MediFind in the treatment of Dysarthria. She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Multiple Sclerosis (MS), Obstructive Sleep Apnea, Transient Ischemic Attack (TIA), and Migraine. Dr. Vijayakumar is board certified in Clinical Neurophysiology, Neurology, Neuromuscular Medicine, Sleep Medicine, and Vascular Neurology.

Kelvin L. Chou, M.D. is a Clinical Professor in the Departments of Neurology and Neurosurgery at Michigan Medicine and was the inaugural Thomas H. and Susan C. Brown Early Career Professor in Neurology. Dr. Chou has been named to the Best Doctors of America list since 2011 and sees all patients with movement disorders (i.e. Parkinson’s disease, tremors, dystonia, Huntington disease), though he has a particular interest in Parkinson’s disease (PD) and deep brain stimulation (DBS). Dr. Chou serves as Co-Director of the STIM (Surgical Therapies Improving Movement) Program and his research focus is on improving the ability to treat movement disorders patients through DBS. He is also an experienced clinical trialist, conducting numerous clinical trials on new therapies for PD, essential tremor and Huntington disease. He directs the Neurology Clinical Trials Organization (NeCTO) and is Lead Medical Director of the Neuroscience and Sensory Clinical Trials Support Unit (CTSU) at Michigan Medicine. He has published over 100 peer-reviewed journal articles, review articles or book chapters on PD and related movement disorders. A strong patient advocate, Dr. Chou is the Education and Outreach Core Director for the U-M Udall Center of Excellence for PD Research and serves on the Professional Advisory Board of the Michigan Parkinson Foundation and the Medical Advisory Board of the International Essential Tremor Foundation (IETF). He has also authored a book for patients and families called Deep Brain Stimulation: A New Life for People with Parkinson's, Dystonia and Essential Tremor. Dr. Chou is rated as a Distinguished provider by MediFind in the treatment of Dysarthria. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Essential Tremor, Drug Induced Dyskinesia, and Deep Brain Stimulation. Dr. Chou is board certified in Neurology.

Dr. Praveen Dayalu is an Associate Professor and the Thomas H. and Susan C. Brown Early Career Professor of Neurology at the University of Michigan. He graduated from medical school at Case Western Reserve University in Cleveland, in 2002, and then completed neurology residency and movement disorders fellowship at Michigan, in 2006. His main focus is clinical management of movement disorders, especially Parkinson disease. His research interests are in Huntington disease and Multiple System Atrophy. He is the Director of the Movement Disorders Fellowship and trains fellows, residents, and medical students. Dr. Dayalu is rated as a Distinguished provider by MediFind in the treatment of Dysarthria. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Huntington Disease, Movement Disorders, Drug Induced Dyskinesia, and Parkinson's Disease. Dr. Dayalu is board certified in Neurology.

After graduating from Tehran University of Medical Sciences in 1990, Dr. Sohrab spent time in Spinal Cord Injury Centers of Iran, in multiple capacities, organizing care and educating different levels of practitioners in providing care for veterans of war. He then spent a few years of general practice, in different parts of Iran, dedicated to providing medical care and organizing Public Health Services, in rural areas. Dr. Sohrab has been practicing, and teaching, general Neurology at the University of Michigan, since 2012. Dr. Sohrab is rated as an Experienced provider by MediFind in the treatment of Dysarthria. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Migraine, Vertigo, Migraine with Brainstem Aura, and Trigeminal Neuralgia.

Dr. Erika Weil completed her undergraduate studies at Purdue University where she studied Neurobiology and physiology. She attended medical school at Indiana University School of Medicine. She then completed Neurology residency, chief residency and fellowship training in Vascular Neurology at Mayo Clinic, Rochester, MN. She completed an additional fellowship training in neuroimaging at Houston Methodist Hospital. Dr. Weil is rated as an Advanced provider by MediFind in the treatment of Dysarthria. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Stroke, Dysarthria, Hemiplegia, Stent Placement, and Transmyocardial Revascularization. Dr. Weil is board certified in Neurology.

Mollie McDermott, MD, MS, is an assistant professor in the Department of Neurology. She completed subspecialty training in Vascular Neurology. She received her bachelor’s degree from Mount Holyoke College and her medical degree from Dartmouth Medical School. Dr. McDermott completed her residency training in Neurology at the University of Michigan, where she served as chief resident from 2014 to 2015. In 2017 she received her master of science degree in clinical research design and statistical analysis from the University of Michigan.Dr. McDermott is interested in acute stroke management, secondary stroke prevention, cardioembolic stroke, and atypical causes of stroke. She is the director of the Telestroke Program and the medical director of the Comprehensive Stroke Center. Dr. Mcdermott is rated as an Advanced provider by MediFind in the treatment of Dysarthria. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Stroke, Dysarthria, Cerebral Amyloid Angiopathy, Stent Placement, and Transmyocardial Revascularization. Dr. Mcdermott is board certified in Neurology and Vascular Neurology.

Garrett Conyers graduated Phi Beta Kappa and with honors from Morehouse College. He received his MD from Harvard Medical School during which time he also completed a Masters in Public Policy from the Harvard Kennedy School of Government. He took two years off in medical school to lead a community participatory research project looking into health inequities in underserved communities in Boston. Dr. Conyers then completed a neurology residency at the Johns Hopkins Hospital followed by a fellowship in vascular neurology at the University of Michigan. Clinically, he has a special interest in moyamoya disease and shared decision making. He is involved in several diversity, equity and inclusion committees nationally. He is passionate about healthcare equity and optimizing systems of care for vulnerable populations, such as imprisoned and socioeconomically disadvantages patients. Dr. Conyers is rated as an Advanced provider by MediFind in the treatment of Dysarthria. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Stroke, Moyamoya Disease, Dysarthria, Thrombectomy, and Transmyocardial Revascularization. Dr. Conyers is board certified in Neurology.

Joseph Carrera is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Carrera is rated as an Advanced provider by MediFind in the treatment of Dysarthria. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Stroke, Fibromuscular Dysplasia (FMD), Transient Ischemic Attack (TIA), Transmyocardial Revascularization, and Stent Placement. Dr. Carrera is board certified in Neurology and Vascular Neurology.

Darin B. Zahuranec, M.D. (Residency 2005), is a professor of neurology in the University of Michigan Medical School. He joined the U-M faculty in 2005 as a clinical lecturer in the Department of Neurology, and was promoted to professor of neurology in 2007.Dr. Zahuranec received his bachelor's degree, summa cum laude, from Case Western Reserve University in Cleveland, Ohio, in 1997, and earned his medical degree from Case Western Reserve in 2001. He completed an internship at University Hospitals of Cleveland; residency in the Department of Neurology at the U-M, where he served as chief resident in 2004-05; and a fellowship in stroke and cerebrovascular disease here.In addition to his U-M appointments, Dr. Zahuranec also has served as a staff physician in the Department of Neurology at the VA Ann Arbor Healthcare System and a research staff physician in emergency medicine at Saint Joseph Mercy Hospital in Ann Arbor.His current research activities include, Pilot Study of Gated Cardiac Magnetic Resonance Imaging for Detection of Embolic Source after Ischemic Stroke, Brain Atrophy in Intracerebral Hemorrhage Patients, Brain Attack Surveillance in Corpus Christi (BASIC), Carotid Occlusion Surgery Study (COSS), and Randomized Evaluation of Recurrent Stroke Comparing Patent Foramen Ovale Closure to Established Current Standard of Care Treatment (RESPECT).Dr. Zahuranec has served as an ad hoc reviewer for Neurology, the New England Journal of Medicine and the Journal of Neuroophthalmology, and currently reviews for Stroke. He is a member of the Stroke Council of the American Heart Association, the American Academy of Neurology and the American Medical Association.His bibliography includes numerous peer-reviewed publications, book chapters, abstracts and clinical papers. Dr. Zahuranec is rated as an Advanced provider by MediFind in the treatment of Dysarthria. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Stroke, Transient Ischemic Attack (TIA), Moyamoya Disease, Thrombectomy, and Stent Placement. Dr. Zahuranec is board certified in Vascular Neurology and Neurology.

Dr. Feldman is the director of the NeuroNetwork for Emerging Therapies at Michigan Medicine and the ALS Center of Excellence at Michigan Medicine. The latter includes the Pranger ALS Clinic, one of the top multidisciplinary clinics caring for those suffering from amyotrophic lateral sclerosis (ALS). She serves as the University of Michigan James W. Albers Distinguished University Professor and the Russell N. DeJong Professor of Neurology at Michigan Medicine. Dr. Feldman is one of the world’s leading authorities on neurodegenerative disease.Dr. Feldman is a compassionate and dedicated physician who cares deeply about her patients. She has been recognized for her clinical excellence by numerous organizations and is annually named as one of the “Best Doctors in America.” Her forward-thinking, collaborative, multidisciplinary approach has transformed how neurodegenerative diseases are diagnosed, treated, and prevented.Dr. Feldman has made significant contributions to biomedical research and clinical care in many critical areas of neurodegenerative disease. She has authored over 530 peer-reviewed publications, 74 book chapters, and 5 books on the pathology, diagnosis, and treatment of neurological diseases. Dr. Feldman has been continuously funded by the NIH since 1989 and is currently the principal or co-investigator of numerous clinical trials and grants. She has received numerous awards and honors throughout her remarkable career, including the University of Michigan’s Early Distinguished Career Award, the Distinguished Faculty Achievement Award, and the Distinguished Alumnus Achievement Award. She was also the first woman in 25 years to receive the Robert S. Schwab Award from the American Clinical Neurophysiology Society. In 2022, Dr. Feldman was awarded the University of Michigan Distinguished Professorship, the highest faculty honor at University of Michigan.Dr. Feldman is actively committed to and involved in professional service. She served as President of the Peripheral Nerve Society from 2007-2009 and President of the American Neurological Association (ANA) from 2011-2013. Dr. Feldman is an elected member of the National Academy of Medicine (NAM) and Association of American Physicians, and a Fellow of the American Association for the Advancement of Science. Dr. Feldman is the Editor of the Contemporary Neurology Series and also serves on a number of editorial boards for leading scientific journals, including The Lancet Neurology, Nature Reviews Neurology, JAMA Neurology and Journal of Neurology, Neurosurgery and Psychiatry. Dr. Feldman is rated as an Advanced provider by MediFind in the treatment of Dysarthria. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Peripheral Neuropathy, Diabetic Neuropathy, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Autonomic Neuropathy. Dr. Feldman is board certified in Neurology and Electrodiagnostic Medicine.

Dr. Hogikyan is Professor and Associate Chairman of Otolaryngology-Head and Neck Surgery in the University of Michigan Medical School, and Professor of Music in the U-M School of Music, Theatre and Dance. He serves as Chief of the Division of Laryngology and General Otolaryngology (LaRGO), and Director of the University of Michigan Vocal Health Center. He is a subspecialist in Laryngology and Clinical Medical Ethics.Dr. Hogikyan received his bachelor of science degree in Cellular and Molecular Biology from the University of Michigan magna cum laude and Phi Beta Kappa in 1982. He graduated from the University of Michigan Medical School cum laude, alpha omega alpha, and with distinction in research in 1988. While in medical school he received a prestigious Howard Hughes Medical Institute-National Institutes of Health research fellowship and spent a year doing molecular genetics research at NIH. His residency in Otolaryngology-Head and Neck Surgery was at Washington University in St Louis, Missouri, and his fellowship in Laryngology was under Dr. Robert Bastian at Loyola University of Chicago. Dr. Hogikyan joined the University of Michigan faculty in 1995. He more recently undertook a fellowship in Clinical Medical Ethics at the University of Chicago MacLean Center for Clinical Medical Ethics, from where he graduated in 2019. Areas of InterestDr. Hogikyan’s clinical interests include all types of voice disorders, as well as airway and swallowing problems. He founded the University of Michigan Vocal Health Center in 1996, including a multidisciplinary clinic for occupational and professional voice users. He also serves as faculty with the Michigan Medicine Clinical Ethics Program.His laryngologic research interests include measurement of voice-related quality of life (V-RQOL), laryngeal paralysis, subglottic stenosis, and respiratory papillomatosis. His ethics-related research interests include the doctor-patient relationship, trust in the surgeon-patient relationship, and ethical considerations for patients with communication disorders.Honors and AwardsDr. Hogikyan has received numerous awards over the course of his career, with notable recent awards including:University of Michigan Medical School: Otolaryngology Teacher of the Year (2004), Dean’s Award for Community Service (2012), Resident Mentorship Award (2015, 2017), Esteemed Clinical Faculty Award (2015), LarGO Division Teaching Award (2018)American Academy of Otolaryngology-Head and Neck Surgery: Honor Award (2009), Jerome C. Goldstein Public Service Award (2018)Triological Society: Triological Thesis Honorable Mention Award for Basic Science Research (2011)American Laryngological Association: Presidential Citation (2017). Dr. Hogikyan is rated as an Advanced provider by MediFind in the treatment of Dysarthria. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Spasmodic Dysphonia, Laryngectomy, and Endoscopy. Dr. Hogikyan is board certified in Otolaryngology-Head & Neck Surgery.

Zach London, M.D. is a Professor in the University of Michigan Medical School. Dr. London grew up in Milwaukee, Wisconsin. He graduated Magna Cum Laude from Brown University in 1997. He attended medical school at the University of Wisconsin – Madison, graduating in 2001. He completed a Preliminary Medicine Internship at St. Joseph Mercy Hospital in Ann Arbor in 2001, followed by Neurology Residency at the University of Michigan. After graduation from residency, he did a one-year fellowship in Clinical Neurophysiology/EMG at the University of Michigan.He joined the University of Michigan faculty as a neuromuscular neurologist in 2006, and has served as Program Director of the neurology residency program. Dr. London’s scholarly focus is the development of interactive educational tools, with a focus on educational boardgames. He is the founder of Neurd Games, which includes popular titles such as The Lesion: Charcot’s Tournament, The Plexus, Endowed Chairs: Neurology, Formaina, and Field Cut. He also created EMG Whiz, a popular web-based EMG training simulator, and mobile applications to teach the tenets of neuroanatomic localization.He has published online learning modules for the American Academy of Neurology and other national organizations, in addition to traditional publishing research regarding medical education and electrodiagnostic studies.Dr. London has been recognized with numerous national teaching awards, including the American Academy of Neurology (AAN) A.B. Baker Lifetime Achievement Award in Neurologic Education in 2023, The American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Innovation Award in 2021, and the American Neurological Association (ANA) Distinguished Teacher Award in 2017. At the University of Michigan, he received the 2013 Silver Shovel Award, the Provost’s Teaching Innovation Prize in 2015, and, in 2017, the Kaiser Permanente Award. Departmental honors include the Status Pedagogicus Award in 2008, and the James Albers Collegiate Professorship in 2018. He has been an honorary member of the GALENS medical society most years since 2011. Dr. London regularly speaks at national meetings on topics of medical education, game development, and clinical neurophysiology. He has served as chair or member of committees and workgroups for the AAN, ANA, AANEM, and ACGME, including serving as the Chair of the Consortium of Neurology Program Directors.Outside his work, Zach London is a founding board member of the Penny Seats Theatre Company in Ann Arbor. He has also composed and released one original song every month since 1993, posting them on his personal website www.hardtaco.org. Dr. London is rated as an Advanced provider by MediFind in the treatment of Dysarthria. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Myasthenia Gravis, Peripheral Neuropathy, Chronic Inflammatory Demyelinating Polyneuropathy, and Chronic Polyradiculoneuritis. Dr. London is board certified in Neuromuscular Medicine, Neurology, and Electrodiagnostic Medicine.

Ann Little is a Neurologist and a Neuroradiologist practicing medicine in Ann Arbor, Michigan. Dr. Little is rated as an Advanced provider by MediFind in the treatment of Dysarthria. She is also highly rated in 63 other conditions, according to our data. Her clinical expertise encompasses Inclusion Body Myositis, Polymyositis, Myasthenia Gravis, Stent Placement, and Transmyocardial Revascularization.

Robbi Kupfer is an Otolaryngologist practicing medicine in Ann Arbor, Michigan. Dr. Kupfer is rated as an Advanced provider by MediFind in the treatment of Dysarthria. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Recurrent Respiratory Papillomatosis, Spasmodic Dysphonia, Perichondritis, Laryngectomy, and Endoscopy. Dr. Kupfer is board certified in Otolaryngology-Head & Neck Surgery.

Dr. Brian M. Kelly is a Professor in the Department of Physical Medicine and Rehabilitation (PMR) at the University of Michigan Medical School and Medical Director for the Division of Orthotics and Prosthetics of the Department of Physical Medicine and Rehabilitation Services at the University of Michigan. Prior to joining the faculty of the University of Michigan in 2002, Dr. Kelly worked in Chicago after graduation from residency. Dr. Kelly has been caring for people that suffer from amputations, trauma, spinal cord injuries, strokes, and traumatic brain injuries for 15 years. He has gained national recognition for his work, lecturing across the country at national meetings on gait evaluation and disorders, amputation, prosthetics, and neurologic disorders. Throughout his career, Dr. Kelly has published numerous articles and chapters on prosthetics and orthotics. In 2014, Dr. Kelly published Prosthetic Restoration of the Upper and Lower Extremity, a new textbook on prosthetic restoration, with his University of Michigan colleagues that reflects their vast clinical experience and teaching skills related to prosthetics. Dr. Kelly has devoted a significant amount of time and energy to the education, training and evaluation of resident physicians. He has been honored with the highest teaching awards available at all of the institutions that he has served. Dr. Kelly is the vice-chair and chair-elect to the National Board of Osteopathic Medical Examiners. He produces examination materials in an effort to demonstrate the resident’s competence on their national board examinations for board certification. Dr. Kelly graduated Cum Laude in 1991 from Aquinas College in Grand Rapids, Michigan. He received his medical degree from Michigan State University in East Lansing, Michigan and completed his residency training at Rush-Presbyterian Medical Center in Chicago, Illinois. Dr. Kelly is rated as an Advanced provider by MediFind in the treatment of Dysarthria. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Phantom Limb Pain, Stroke, Guillain-Barre Syndrome, and Miller-Fisher Syndrome. Dr. Kelly is board certified in Physical Medicine & Rehab.

Sharan Srinivasan is a Neurologist practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 10 years. Dr. Srinivasan is rated as an Advanced provider by MediFind in the treatment of Dysarthria. He is also highly rated in 108 other conditions, according to our data. His clinical expertise encompasses Hereditary Ataxia, Olivopontocerebellar Atrophy, Spinocerebellar Ataxia Type 4, and Spinocerebellar Ataxia Type 5. Dr. Srinivasan is board certified in Neurology.

Kara J. Wyant, MD, is a clinical lecturer in the Department of Neurology. She received her bachelor’s degrees in mathematics and music from Ohio Northern University, and medical degree from the University of Toledo College of Medicine. Dr. Wyant completed her neurology residency training at the University of Pittsburgh Medical Center, where she served as chief resident from 2015-2016. She is currently pursuing a fellowship in movement disorders at the University of Michigan focusing on the medical and surgical management of patients with Parkinson disease and parkinsonism. Dr. Wyant also serves on the neurohospitalist service at University Hospital, and participates in teleneurology consults for MidMichigan Health. Dr. (md) is rated as an Advanced provider by MediFind in the treatment of Dysarthria. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Drug Induced Dyskinesia, Parkinson's Disease, Movement Disorders, Dopa-Responsive Dystonia, and Deep Brain Stimulation. Dr. (md) is board certified in Neurology.

Roger L. Albin, M.D. (Residency 1986), is a professor of neurology, associate chair for research and co-director of the Movement Disorders Clinic in the Department of Neurology in the University of Michigan Medical School. In addition, he serves as chief of neuroscience research at the VA Ann Arbor Healthcare System Geriatric Research Education and Clinical Center.Dr. Albin joined the U-M faculty in 1988 as an instructor in the Department of Neurology. He was promoted to assistant professor in 1989; associate professor in 1994; and achieved his current rank of full professor in 2000.After completing his undergraduate degree at Oberlin College in Ohio, Dr. Albin earned his medical degree from the University of Pittsburgh School of Medicine in 1982, and completed his residency at the University of Michigan in 1986. He also completed a movement disorders fellowship in 1988 under Drs. Anne Young and John Penney.His clinical and research interests include the underlying neurobiologic causes of the clinical features of movement disorders, basal ganglia structure and function, Parkinson's disease, Tourette syndrome, dementias, dystonias and Huntington's disease. His laboratory is pursuing work on basic mechanisms of neurodegeneration in Huntington disease using mouse genetic models. Dr. Albin also has participated in neuroprotective clinical trials for both Huntington's disease and Parkinson's disease.The present focus of Dr. Albin's group is uncovering the basis for non-motor (sleep disorders, depression, dementia, autonomic dysfunction) problems in Parkinson's disease. He is very interested in applying positron emission tomography (PET) imaging methods to improve diagnosis of dementing disorders like Alzheimer's disease. The hope is that understanding how specific brain alterations cause specific clinical features will lead to improved treatments.Dr. Albin currently serves as a site investigator for the National Institutes of Health (NIH) Exploratory Trials in Parkinson disease (NET-PD) initiative. His work is supported by grants from the NIH, the Michael J. Fox Foundation and the High Q Foundation.A member of the American Academy of Neurology, the American Association for the Advancement of Science, the American Neurologic Association, and the Society for Neuroscience, Dr. Albin currently serves on the editorial boards of Experimental Neurology, Neurology and Neurobiology of Disease. Dr. Albin is rated as an Advanced provider by MediFind in the treatment of Dysarthria. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Movement Disorders, Parkinson's Disease, Huntington Disease, Dementia, and Deep Brain Stimulation. Dr. Albin is board certified in Neurology.

Henry L. Paulson, M.D., Ph.D., is the Lucile Groff Professor of Neurology for Alzheimer's Disease and Related Disorders in the Department of Neurology at the University of Michigan. Dr. Paulson joined the U-M faculty in 2007, and he currently directs the Michigan Alzheimer’s Disease Center (MADC) and co-direct the U-M Protein Folding Diseases Initiative.Dr. Paulson received his medical degree and doctorate in Cell Biology from Yale University in 1990. He then completed a neurology residency and neurogenetics/movement disorders fellowships at the University of Pennsylvania. In 1997, he joined the Neurology faculty at the University of Iowa, where he remained until 2007.Dr. Paulson's research and clinical interests concern the causes and treatment of age-related neurodegenerative diseases, with an emphasis on polyglutamine diseases, Alzheimer's disease and frontotemporal dementia. In 1997, his lab described abnormal protein aggregates in the polyglutamine diseases, which now are recognized as a pathological hallmark in this important class of inherited diseases. Using test tube, cell-based and animal models, he has contributed to advances in the understanding of various neurodegenerative diseases. His lab also has helped pioneer the use of gene silencing methods as potential therapy for the many neurological disorders caused by toxic mutant genes.Nationally, Dr. Paulson has directed popular courses at the American Academy of Neurology meetings, serves on the scientific advisory boards of numerous disease-related national organizations, and is past Chair of the Board of Scientific Counselors at the National Institute for Neurological Disorders and Stroke at the National Institutes of Health.Among his awards, Dr. Paulson is an Ellison Medical Foundation New Scholar in Aging, a semifinalist for the W.M. Keck Foundation Young Scholars in Medical Research, and a recipient of the Paul Beeson Physician Faculty Scholar in Aging Award from the American Federation for Aging Research. Dr. Paulson is rated as an Advanced provider by MediFind in the treatment of Dysarthria. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Spinocerebellar Ataxia Type 3, Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, and Drug Induced Dyskinesia. Dr. Paulson is board certified in Neurology.